Increased Private, Government Investment Needed To Address Antimicrobial Resistance

Project Syndicate: A Call to Antimicrobial Arms
Jim O’Neill, honorary professor of economics at Manchester University, visiting research fellow at Bruegel, and fellow of the University of Cambridge’s Center for Rising Powers

“…[W]e do not invest enough in research and development. … That is why I am calling on international donors — philanthropic and governmental alike — to work with the Review on Antimicrobial Resistance to create a new fund to support R&D in this important area. … A solution to antimicrobial resistance need not be expensive. It is likely to cost the world much less than 0.1 percent of global GDP. Weighed against the alternative — $100 trillion in lost production by 2050 and ten million lives lost every year — it is clearly one of the wisest investments we can make” (2/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.